We are live on ! Find out more
BIA

Biondo Investment Advisors Portfolio holdings

AUM $780M
1-Year Est. Return 21.03%
This Fund
S&P 500
This Quarter Est. Return
+14.28%
1 Year Est. Return
+21.03%
3 Year Est. Return
+89.14%
5 Year Est. Return
+116.93%
10 Year Est. Return
+716.27%
AUM
$461M
AUM Growth
+$65.2M
Cap. Flow
+$19.7M
Cap. Flow %
4.27%
Top 10 Hldgs %
50.49%
Holding
85
New
8
Increased
60
Reduced
8
Closed
2

Top Buys

Rank Stock Value
1
XOM icon
ExxonMobil
XOM
+$5.52M
2
VFC icon
VF Corp
VFC
+$4.54M
3
EW icon
Edwards Lifesciences
EW
+$3.88M
4
ISRG icon
Intuitive Surgical
ISRG
+$1.86M
5
ZTS icon
Zoetis
ZTS
+$1.52M

Sector Composition

Rank Sector Weight
1 Healthcare 36.15%
2 Technology 24.33%
3 Financials 9.78%
4 Consumer Discretionary 9.46%
5 Communication Services 4.8%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BBBY
26
DELISTED
Bed Bath & Beyond Inc
BBBY
$5.75M 1.25%
383,500
+119,500
+45% +$1.38M
VZ icon
27
Verizon
VZ
$196B
$5.73M 1.24%
96,299
+3,473
+4% +$202K
AMGN icon
28
Amgen
AMGN
$222B
$5.7M 1.24%
22,276
+559
+3% +$138K
ABBV icon
29
AbbVie
ABBV
$435B
$5.64M 1.22%
64,357
+1,958
+3% +$184K
LMT icon
30
Lockheed Martin
LMT
$136B
$5.56M 1.21%
14,428
+605
+4% +$231K
BMY icon
31
Bristol-Myers Squibb
BMY
$132B
$5.25M 1.14%
87,142
+3,111
+4% +$187K
SO icon
32
Southern Company
SO
$107B
$5.14M 1.11%
93,666
+4,532
+5% +$242K
SIVB
33
DELISTED
SVB Financial Group
SIVB
$4.99M 1.08%
20,729
+80
+0.4% +$18.8K
VFC icon
34
VF Corp
VFC
$5.89B
$4.94M 1.07%
+70,315
New +$4.54M
GIS icon
35
General Mills
GIS
$19.7B
$4.83M 1.05%
78,385
+2,080
+3% +$130K
DUK icon
36
Duke Energy
DUK
$97.3B
$4.66M 1.01%
52,018
+2,659
+5% +$219K
MMM icon
37
3M
MMM
$94.3B
$4.66M 1.01%
34,446
+1,393
+4% +$187K
XOM icon
38
ExxonMobil
XOM
$634B
$4.63M 1%
+134,943
New +$5.52M
TFC icon
39
Truist Financial
TFC
$64B
$3.94M 0.85%
102,354
+5,643
+6% +$213K
CVX icon
40
Chevron
CVX
$366B
$3.54M 0.77%
48,329
+2,886
+6% +$243K
ITW icon
41
Illinois Tool Works
ITW
$84.5B
$2.99M 0.65%
15,470
+600
+4% +$114K
BA icon
42
Boeing
BA
$185B
$2.92M 0.63%
17,646
+62
+0.4% +$10.6K
ZTS icon
43
Zoetis
ZTS
$30B
$2.3M 0.5%
13,915
+9,900
+247% +$1.52M
REGN icon
44
Regeneron Pharmaceuticals
REGN
$80.8B
$1.88M 0.41%
3,350
SBUX icon
45
Starbucks
SBUX
$120B
$1.86M 0.4%
21,620
+360
+2% +$28.7K
ADP icon
46
Automatic Data Processing
ADP
$108B
$1.84M 0.4%
13,173
+878
+7% +$123K
NOW icon
47
ServiceNow
NOW
$129B
$1.22M 0.26%
12,535
+90
+0.7% +$8.04K
IWF icon
48
iShares Russell 1000 Growth ETF
IWF
$128B
$1.15M 0.25%
21,236
+1,052
+5% +$55.4K
MTUM icon
49
iShares MSCI USA Momentum Factor ETF
MTUM
$26.2B
$1.07M 0.23%
7,284
+403
+6% +$57.6K
IWP icon
50
iShares Russell Mid-Cap Growth ETF
IWP
$20.7B
$1.04M 0.23%
12,070
+724
+6% +$61.1K

Similar funds

Biondo Investment Advisors's Q3 2020 Portfolio in Review

As of Q3 2020, Biondo Investment Advisors held 85 positions worth $461M, up 16% from $396M the previous quarter. Its ten largest holdings account for 50% of the portfolio.

Biondo Investment Advisors deployed $19.7M of net new capital in Q3 2020, opening 8 new positions and adding to 60 existing holdings. Its largest new stake was ExxonMobil: 134,943 shares worth $4.63M.

By sector, the portfolio is most concentrated in Healthcare at 36% of assets, down from 38% a quarter earlier, followed by Technology and Financials.

On the sell side, the largest reduction was iShares Core High Dividend ETF, an estimated $587K trimmed.

  • Biondo Investment Advisors's largest Q3 2020 buy was ExxonMobil: 134,943 shares worth $4.63M.
  • Biondo Investment Advisors added most to Edwards Lifesciences in Q3 2020, an estimated $3.88M increase.
  • Biondo Investment Advisors's biggest Q3 2020 reduction was iShares Core High Dividend ETF, cutting an estimated $587K.
  • Biondo Investment Advisors fully exited AT&T in Q3 2020, selling an estimated $3.33M.
  • Biondo Investment Advisors's ten largest holdings make up 50% of its $461M portfolio in Q3 2020.
  • Biondo Investment Advisors opened 8 new positions and closed 2 in Q3 2020.
  • Biondo Investment Advisors's portfolio value rose 16% quarter-over-quarter to $461M.

Based on Biondo Investment Advisors's 13F filing for Q3 2020, filed 5 Nov 2020.